Clinical Research
Copyright ©The Author(s) 2003.
World J Gastroenterol. Apr 15, 2003; 9(4): 836-842
Published online Apr 15, 2003. doi: 10.3748/wjg.v9.i4.836
Table 1 Degree of inflammatory cell infiltration compared with the degree of decrease of original glands in gastric mucosa n (%)
GroupnDegree of inflammatory cell infiltration
Degree decrease of glands propria
< 1/3> 1/3 < 2/3> 2/3< 1/31/3 < 2/3> 2/3
NC15
CSG-woS1811 (61.1)6 (33.3)1 (5.6)1 (5.6)
CAG-woS95 (55.6)3 (33.3)1 (11.1)5 (55.6)d3 (33.3)
F-TwS56
CSG-wS6826 (38.2)c32 (47.1)10 (14.7)
CAG-Ws6419 (29.7)df21 (32.8)24 (37.5)df23 (35.9)d23 (35.9)18 (28.1)
Table 2 Focal background lesions in non-focal site of gastric mucosa n (%)
Focal lesionsCSG-woS (n = 18)
CAG-woS (n = 9)
CSG-wS (n = 68)
CAG-Ws (n = 64)
Gastric antrumGastric bodyGastric antrumGastric bodyGastric antrumGastric bodyGastric antrumGastric body
Atrophic1 (5.6)0 (0.0)1 (11.1)a0 (0.0)21 (30.9)bd11 (16.2)47 (73.4)bdj27 (42.2)j
inflammatory lesion
IM4 (22.2)1 (5.6)5 (55.6)b2 (22.2)b27 (39.7)bc5 (7.4)d59 (92.2)bdj13 (20.3)b
Micro ulcer1 (5.6)1 (5.6)3 (33.3)b1 (11.1)a11 (16.2)2 (2.9)c28 (43.8)bdj9 (14.1)aj
Table 3 Ultrastructures of gastric mucosa epithelial cell nuclei n (%)
GroupnAppeararce
Chromatin
Nucleoli
Nucleoplasmic ratio > 1Nuclear lobulationmargination or homogeneityPerinuclear concentrationhypertrophy or marginationlooping
NC151 (6.7)1 (6.7)
CSG-woS181 ( 5.6)4 (22.2)b1 (5.6)1 (5.6)1 (5.6)
CAG-woS92 (22.2)d2 (22.2)7 (77.8)bd3 (33.3)bd2 (22.2)d4 (44.4)d
F-TwS563 (5.4)df3 (5.4)f1 (1.8)f
CSG-wS685 ( 5.7)f2 (2.9)f7 (10.3)cf5 (7.4)f2 (2.9)f2 (2.9)f
CAG-Ws6420 (31.3)dj9 (29.7)j33 (51.6)bdhj29 (45.3)dfhj27 (42.2)dfhj14 (21.9)dgi
Table 4 Mitochondria ultrastructures of gastric mucosa epithelial cells. (x-± s)
GroupnNumberSwelling & overgrowth (%)Matrix-discoloration (%)Vacuolar degencration (%)Pyknosis (%)Crista numberCrista fragmentation & derangement (%)
NC1586.5 ± 27.33.4 ± 1.63.0 ± 1.12.9 ± 1.91.1 ± 0.812.8 ± 3.22.2 ± 1.1
CSG-woS1885.3 ± 22.23.9 ± 1.13.9 ± 2.23.2 ± 1.21.4 ± 0.911.4 ± 2.43.1 ± 1.3
CAG-woS983.8 ± 17.34.4 ± 2.44.3 ± 2.93.3 ± 1.11.7 ± 0.811.4 ± 2.13.2 ± 1.2
F-TwS5683.1 ± 22.85.4 ± 2.9bd4.4 ± 2.42.9 ± 1.81.2 ± 0.711.2 ± 2.33.9 ± 1.2bc
CSG-wS6865.4 ± 21.1bdfh7.2 ± 3.8bdfg7.9 ± 5.0bdfh6.4 ± 4.5bdfh1.9 ± 0.9bch8.2 ± 3.2bdfh5.8 ± 3.1bdfh
CAG-wS6452.2 ± 20.8bdfhj10.9 ± 4.5bdfhj11.7 ± 8.6bdfhj11.6 ± 7.7bdfhj3.7 ± 1.1bdfhj6.9 ± 3.5bdfhji8.9 ± 3.7bdfhj
Table 5 Gastric mucosa trace elements, cAMP and 3H-TdRLCT (x-± s)
GroupnGastric mucosa
Blood 3H-TdRLCT (Bq/L)
Zn (WT%)Cu (WT%)cAMP (Pmol/g)SOD (u/g)
NC154.1 ± 1.05.2 ± 0.815.9 ± 1.5170.5 ± 6.11079.7 ± 227.4
CSG-woS183.7 ± 1.25.1 ± 1.815.6 ± 0.9167.2 ± 5.3924.5 ± 234.9
CAG-woS93.3 ± 1.04.8 ± 0.914.9 ± 0.7a166.1 ± 4.2a887.7 ± 243.6
F-TwS563.5 ± 1.4a4.5 ± 1.0a15.7 ± 1.4e167.9 ± 5.7932.1 ± 2449.3a
CSG-wS682.8 ± 1.9bcg4.0 ± 1.5aceg14.2 ± 1.8bdeh163.3 ± 5.6bdh867.3 ± 240.5bc
CAG-wS642.0 ± 1.8bdfhi3.4 ± 1.5bdfhj13.4 ± 1.8bdfhi161.2 ± 4.3bdfhi800.9 ± 221.8bdi
Table 6 Epithelial nuclei and mitochondria Zn, Cu in gastric mucosa (x-± s)
GroupnNuclei
Mitochondria
Serum
Zn (AT%)Cu (AT%)DNA (IOD)Zn (AT%)Cu (AT%)LPO (umol/L)
NC157.6 ± 0.458.4 ± 0.312.6 ± 2.79.2 ± 0.558.3 ± 0.32.6 ± 0.6
CSG-woS187.8 ± 0.358.6 ± 0.413.0 ± 3.18.9 ± 0.558.2 ± 0.32.9 ± 0.4
CAG-woS97.8 ± 0.3a58.7 ± 0.3a14.3 ± 2.88.8 ± 0.4a57.5 ± 0.2bd3.1 ± 0.4
F-TwS567.9 ± 0.4a58.7 ± 0.5a13.5 ± 4.68.9 ± 0.5a58.0 ± 0.3af2.9 ± 0.7
CSG-wS688.1 ± 0.5bdfh58.9 ± 0.5bdh15.2 ± 3.2bcg8.6 ± 0.5bh57.8 ± 0.3bdfh4.2 ± 0.7bdfh
CAG-Ws648.6 ± 0.4bdfhj59.3 ± 0.5bdfhj16.5 ± 3.1bdehi8.3 ± 0.4bdfhj57.5 ± 0.3bdhj4.5 ± 0.6bdfhi